Subject: April DNCB Support Group
From: [email-masked]
Date: Wed, 27 Mar 1996 07:33:45 -0500

"What do you mean protease
 inhibitors don't work?"

Find out about the immune system, CD8s and how the inexpensive, non-toxic
treatment DNCB can strengthen cellular immune responses in the battle against
HIV.

DNCB (dinitrochlorobenzene) is a potent topical contact sensitizer that when
used regularly boosts cellular immune responses resulting in increased
numbers of CD8 cytotoxic T lymphocytes (CTL) and natural killer (NK) cells.
Studies of long-term nonprogressors have demonstrated that they have strong
cellular immunity with high levels of these protective cells.

Virtually all opportunistic infections in AIDS are of an intracellular nature
and can only be controlled by a cellular immune response; therefore it is
important to avoid antiviral therapies that compromise this protective arm of
your immune system. DNCB provides an inexpensive, non-toxic alternative that
strengthens cellular immunity in an effort to delay disease progression and
onset of O.I.s.

Join the monthly gathering of ACT UP San Francisco's DNCB Treatment Group  to
find out more about CD8s, the science behind AIDS and boosting your cellular
immunity to fight HIV. 

Thursday, April 4, 1996 at 7:30 PM
Gazebo Room at Davies Medical Center
(445 Castro Street at Duboce above Emergency Room)

For more information on cellular immunity or obtaining DNCB, call the DNCB
Treatment Group at (415) 954-8896. You can contact   ACT UP San Francisco at
(415) 522-2907.